Sign in
Taking people in United StatesEarly phase 1

Brain imaging to compare laryngeal dystonia and voice tremor

Studies brain activity differences between laryngeal dystonia and voice tremor in adults.

Key facts

Who runs it
Massachusetts Eye and Ear Infirmary
Where
Boston, United StatesSee the site
Trial code
Registry title
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
Status
Recruiting
Phase
Early phase 1
People taking part
165 people, planned
Started
24 Mar 2022
Expected to end
31 Aug 2027
Type of study
Interventional, 5 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Brain imaging
  • Laryngeal sensory block with topical bupivacaine
Record updated
2 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with laryngeal dystonia (spasmodic dysphonia) or voice tremor, and healthy volunteers for comparison. It uses brain scans to study how these voice disorders differ.

Age
18-80 years
Sex
Males and females
Disease stage
Patients must have laryngeal dystonia or voice tremor and be fully symptomatic. Healthy volunteers must have no neurological, psychiatric or throat and voice-box problems. All must be native English speakers, right-handed, with normal thinking and memory.
Earlier treatment
Patients must be at least 3 months past their last botulinum toxin injection and fully symptomatic. People taking medicines that affect the brain and nerves cannot join. People with past head or neck surgery that changed anatomy or nerves cannot join.

Main reasons for not taking part

  • Pregnant or breastfeeding women
  • Other neurological, psychiatric or voice-box problems, or any other form of dystonia
  • Dystonia symptoms at rest or mirror dystonia
  • Unable to give informed consent
  • Tattoos or metal objects in the body that cannot be removed for MRI

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Males and females of diverse racial and ethnic background
  • Age 18-80 years
  • Native English speakers
  • Right-handed
  • Normal cognitive status
  • Patients will have laryngeal dystonia or voice tremor
  • Healthy controls will be healthy individuals without neurological, psychiatric or otolaryngological problems

Who cannot take part

  • Patients who are not symptomatic due to treatment with botulinum toxin injections into the affected muscles. The duration of positive effects of botulinum toxin varies from patient to patient but lasts, on average, for 3-4 months. All patients will be evaluated to ensure that they are fully symptomatic and are at least 3 months post-injection before participation
  • To avoid the confounding effect of centrally acting drugs, all study participants will be questioned about any prescribed or over-the-counter medications as part of their initial screening. Those patients who receive medication(s) affecting the central nervous system will be excluded
  • Patients will be asked whether they have undergone any head or neck surgery, which resulted in changes in regional anatomy or innervation. Because brain or laryngeal surgery may potentially lead to brain structure and function re-organization, all patients with such a history will be excluded
  • Subjects with a past or present medical history of (a) neurological problems, such as stroke, movement disorders (other than specified LD and VT in the patient groups), brain tumors, traumatic brain injury with loss of consciousness, ataxias, myopathies, myasthenia gravis, demyelinating diseases; (b) psychiatric problems, such as schizophrenia, bipolar depression, obsessive-compulsive disorder, alcoholism, drug dependence; (c) laryngeal problems, such as vocal fold paralysis, paresis, vocal fold nodules and polyps, carcinoma, chronic laryngitis
  • Subjects who have certain tattoos and ferromagnetic objects in their bodies (e.g., implanted stimulators, surgical clips, prosthesis, artificial heart valve) that cannot be removed for MRI studies
  • Subjects who are incapable of giving informed consent
  • Pregnant or breastfeeding women until a time when they are no longer pregnant or breastfeeding. All women of childbearing potential will have a urine pregnancy test performed before MRI, which must be negative for participation in the imaging studies
  • Patients with any other form of dystonia
  • Patients who have dystonia symptoms at rest or have a presence of mirror dystonia

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Where in United States

  • Massachusetts Eye and Ear and University of California San FranciscoBoston, United StatesContact: Kristina Simonyan, MD, PhDTaking people

About the trial

What the trial wants to find out

The researchers will examine functional neural correlates that differentiate between laryngeal dystonia and voice tremor and contribute to disorder-specific pathophysiology using a cross-disciplinary approach of multimodal brain imaging.

The 5 groups in the trial

  • Spatial and temporal CNS pathophysiology of laryngeal dystonia and voice tremorOther group

    Simultaneous fMRI with EEG and MEG imaging will be used to examine neural dynamics during phonation.

    Treatment: Brain imaging

  • Sensorimotor modulations of laryngeal dystonia and voice tremor with bupivacaineExisting treatment, for comparison

    Topical laryngeal block (1 ml of 0.75% bupivacaine solution) will be used to modulate somatosensory feedback from the laryngeal mucosa during speech production and examine associated changes in brain activity.

    Treatment: Laryngeal sensory block with topical bupivacaine

  • Motor learning and CNS pathophysiology of laryngeal dystonia and voice tremorOther group

    Implicit learning of the production of motor sequences will be examined during simultaneous fMRI/EEG and MEG imaging. Sensorimotor adaptation of speech production during MEG imaging will be examined during perturbing pitch or formants of auditory feedback consistently during speech production and examining the behavioral and neural correlates of the resulting across-trial adaptation responses.

    Treatment: Brain imaging

  • Placebo effects in laryngeal dystonia and voice tremorPlacebo, for comparison

    1 ml of saline placebo matching to 1 ml of 0.75% bupivacaine solution will be used for a comparison with the topical laryngeal block to modulate somatosensory feedback from the laryngeal mucosa during speech production and examine associated changes in brain activity.

  • Auditory feedback processing in laryngeal dystonia and voice tremorOther group

    The role of auditory feedback processing on task-induced speech sensorimotor activity will be examined using MEG imaging during perturbing pitch or formants of auditory feedback, unpredictably during speech production, and examining the behavioral and neural correlates of the resulting within-trial compensation responses.

    Treatment: Brain imaging

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor
Plain-language title
Brain imaging to compare laryngeal dystonia and voice tremorGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05216770, who can take part
Record updated
2 December 2025